Navigation Links
Renowned medical genetics pioneer to join LA BioMed faculty
Date:2/13/2013

LOS ANGELES (Feb. 13, 2013) Jerome I. Rotter, MD, a pioneer in the field of medical genetics, is joining the faculty at Los Angeles Biomedical Research Institute (LA BioMed) and bringing a team of experts to found a new institute focused on improving the health of the diverse communities served by LA BioMed and Harbor-UCLA Medical Center, David I. Meyer, PhD, LA BioMed president and CEO, announced today.

Known as the LA BioMed Institute for Translational Genomics and Population Sciences, it will employ core technologies used to analyze genomics the entirety of a human's genetic makeup to improve the health of the Hispanic, African-American and Asian populations that compose the patients and family members of the community served by LA BioMed and Harbor-UCLA Medical Center.

"We are so very fortunate to have such a distinguished investigator and his team bringing their world-class research program to LA BioMed," said Meyer. "Jerome Rotter and his colleagues Ida Chen, Xiuqing Guo and Kent Taylor are enormously successful researchers whose pioneering studies in genomics and population sciences have been cited by scientists around the globe. They will bring an exciting new dimension of research to LA BioMed, which will have applicability to almost every field of study on our campus."

Dr. Rotter and his colleagues specialize in the study of the genetics of common chronic diseases, such as diabetes and hypertension, in Hispanics, African-Americans and Asians. Such studies serve as the basis for personalized medicine, which are medical treatments and therapies tailor-made for each patient based on gender and racial and ethnic background.

"Our job is to bring modern genomic technologies to the understanding of disease, the prevention of disease and the development of therapies for disease in minority populations," said Dr. Rotter. "There is no better place for us to conduct our research than LA BioMed where we will have access to a diverse population group, the extensive expertise of the campus investigators in clinical research and a supportive research environment. This appointment will enhance our studies into the influence of ethnicity on disease and enable us to further expand our research into health outcomes among minority populations."

Dr. Rotter graduated Summa Cum Laude from UCLA with a BS in 1970 and an MD in 1973. He first came to Harbor-UCLA Medical Center for his medical student rotations in 1971 and joined Harbor's medical genetics faculty in 1978, becoming Harbor's director of the section on Genetic Epidemiology and Population Genetics.

He left Harbor in 1986 to join Cedars-Sinai Medical Center where he has served as director of research of the Medical Genetics Institute and director of the Division of Medical Genetics. He's also a UCLA and Cedars professor of medicine, pediatrics and human genetics, and he has held the Board of Governors' Chair in Medical Genetics at Cedars.

Dr. Rotter pioneered the genetics of common diseases, using approaches of intermediate phenotypes and genetic heterogeneity in diabetes, inflammatory bowel disease, atherosclerosis, lipid disorders, hypertension, statin response and insulin resistance. He holds 20 patents, has published 420 peer-reviewed articles and has authored or co-authored 70 books and book chapters. He has received multiple accolades, including LA BioMed's highest honor as an LA BioMed "Legend."


'/>"/>

Contact: Laura Mecoy
lmecoy@labiomed.org
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Related medicine news :

1. Renowned Hockey Trainer Talks Hockey Hernia
2. Renowned Cosmetic and Plastic Surgeon, Ronald L. Moy, M.D. to Present at Upcoming AACS Meeting on TriPollar, a Breakthrough in Radio Frequency Technology
3. Atlantic Spine Center Announces New Web Content on Sciatica Treatment; Renowned Surgeon Dr. Kaixuan Liu on Information and Help for Sciatica Victims
4. Renowned Master of Wine Jeannie Cho Lee Appointed Professor of Practice (Wine) by PolyU
5. Renowned Pittsburgh Plastic Surgeon to Be Keynote Speaker at Three Prestigious Conferences
6. Urban Dermatology Turns to Palomar Medical Technologies for its Vectus Hair Removal Laser Tool
7. Inside Job: Medical Negligence Lawyers at Console & Hollawell Comment on Risks to Dialysis Patients and Impending Legal Action Over Fresenius Controversy
8. First Choice Emergency Room Names Dr. Shiraz Pirali Medical Director of New Katy, Texas Facility
9. Research fellowships to advance medical treatments and bring new science to market
10. QuickMedical Introduces New QM-Elite Non-Woven Disposable Face Masks, Shoe Covers, Bouffants and Medical Shorts
11. Dr. Stephen Van Roekel Named Facility Medical Director of First Choice Emergency Room’s New Austin, Texas Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Cranbury, NJ (PRWEB) , ... February 23, 2017 ... ... Cure®, the pre-eminent publication and community for those in the fight against cancer, ... was important in their success. HRA will release top-line findings in a ...
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and only nursing quality ... conference – Empowerment, Value and Collaboration – in Seattle, WA on October 23, 2017. ... Mason Health System in Seattle since 2000. In addition to his role at Virginia ...
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for standing ... sit stand solutions representative to the Minneapolis Home and Garden Show which is being ... that is garnering national attention is the Minneapolis Convention Center. , From its ...
(Date:2/22/2017)... East Setauket, New York (PRWEB) , ... February ... ... the main floor entrance and lobby of a new healthcare contact center in ... gleaming results. , One of the nation’s largest healthcare systems recently invested $51 ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell therapy ... The technology is so cutting edge, in fact, the U.S. Food and Drug ... procedures. However, successful patient outcomes in certain clinical stem cell procedures have shown ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , February 23, 2017 ... report on the global market for intraoperative imaging, ... presently valued at US$ 513.9 million. According to ... keep surging on the grounds of increasing adoption ... the field of diagnostic imaging for neurosurgeries. The ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Cardiac Prosthetic Devices ... over the next decade to reach approximately $8.9 billion by 2025. ... for all the given segments on global as well as regional ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology: